S1PR1 and myocardial infarction: In animal model, SphK activity was significantly reduced in uninfarcted myocardium (RM) in the first 2 weeks after MI, but oral SEW2871, a selective agonist of the S1PR1, effectively reduced RM‐induced apoptosis by restoring Akt phosphorylation levels.32